The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation

BACKGROUND. Assessment of donor-specific cell-free DNA (dscfDNA) in the recipient is emerging as a noninvasive biomarker of organ rejection after transplantation. We previously developed a digital polymerase chain reaction (PCR)-based approach that readily measures dscfDNA within clinically relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Su Kah, Do, Hongdo, Testro, Adam, Pavlovic, Julie, Vago, Angela, Lokan, Julie, Jones, Robert M., Christophi, Christopher, Dobrovic, Alexander, Muralidharan, Vijayaragavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616138/
https://www.ncbi.nlm.nih.gov/pubmed/31334336
http://dx.doi.org/10.1097/TXD.0000000000000902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616138/
https://www.ncbi.nlm.nih.gov/pubmed/31334336
http://dx.doi.org/10.1097/TXD.0000000000000902

Ejemplares similares